ClinicalTrials.Veeva

Menu

Characterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients (EUmetriosis)

M

Medical University of Lublin

Status

Not yet enrolling

Conditions

Endometriosis

Study type

Observational

Funder types

Other

Identifiers

NCT06897436
Project 101157146-EUmetriosis (Other Grant/Funding Number)
101157146

Details and patient eligibility

About

The EUmetriosis project aims to address the most important unmet needs of endometriosis sufferers to advance patient care. The objectives cover all main aspects of disease management, including elucidating the pathogenesis, diagnosing the condition promptly and efficiently, facilitating care by implementing self-management strategies, raising awareness and promoting policy changes. The objectives comprise individual yet intersecting pieces of a puzzle which, when positioned correctly, can immensely improve disease perception and understanding to enhance patient care. The project will prioritise the needs and wants of modern-day patients, focused on providing easily accessible and noninvasive therapeutic options. Combining all these elements in a well-coordinated project is pivotal to relieving the heavy burden endometriosis places on European society as a whole.

Full description

EUmetriosis will generate new knowledge in the field of endometriosis, its drivers and consequences, as well as biological determinants, which will result in a better understanding of endometriosis pathogenesis and the factors involved. Specifically, the project will assess the role of the immune cells, diet, cognitive behaviour and other related factors in disease pathogenesis, and develop strategies on how to alleviate endometriosis-associated pain, enhance quality of life and improve outcomes for patients. The knowledge base (like the association between nutrition, epigenetics, the microbiome and endometriosis) and methodologies generated within the project will drive the fields of gynaecology, primary care, pain medicine, urology and gastroenterology forward. Finally, through the collection of evidence for effective self-management strategies, the project will pave the path for more patient-tailored health policies. The project aims to link different stakeholder groups involved in this field, like clinicians, patients, healthcare insurers/payers and other researchers in women's health. With this multidisciplinary consortium, EUmetriosis will maximise its impact by creating therapeutic and diagnostic endometriosis solutions best suited to real-world applications, with a clear strategy for implementation.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women with a clinical and/or ultrasound diagnosis of endometriosis who are candidates for surgery
  • Age between 18 and 50 years
  • Pre-menopausal status
  • Experiencing regular menstruation
  • Willing to collect menstrual effluent
  • Signature of informed consent to the study

Exclusion criteria

  • Age below 18 years
  • Post-Menopausal status
  • Presence of Crohn's disease
  • Presence of Ulcerative Colitis
  • Presence of short bowel syndrome or another chronic inflammatory disease
  • Use immunosuppressive medication
  • Receiving contraceptive hormone therapy
  • Pregnant
  • Presence/history of malignancy

Trial design

60 participants in 1 patient group

study group
Description:
pre-menopausal adult women with clinically and/or ultrasound-diagnosed endometriosis, age between 18 and 40 years, with regular menstruation, without autoimmune diseases, without malignant diseases

Trial contacts and locations

0

Loading...

Central trial contact

Marek Gogacz, professor; Iwona Wertel, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems